|
Drug Therapy
Citations 181-190 of 200 total displayed.
|
Past content
(since May 1999):
|
- Original Contributions
Treatment of Wilson Disease With Ammonium Tetrathiomolybdate: III. Initial Therapy in a Total of 55 Neurologically Affected Patients and Follow-up With Zinc Therapy
- George J. Brewer; Peter Hedera; Karen J. Kluin; Martha Carlson; Fred Askari; Robert B. Dick; Julia Sitterly; John K. Fink
Arch Neurol 2003; 60: 379-385.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Cortical Myoclonus During Lithium Exposure
- John N. Caviness; Virgilio G. H. Evidente
Arch Neurol 2003; 60: 401-404.
[Abstract]
[Full text]
[PDF]
- Neurological Reviews
The Reach of Neurology
- C. Miller Fisher
Arch Neurol 2003; 60: 173-177.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Elevated Plasma Homocysteine Levels in Patients Treated With Levodopa: Association With Vascular Disease
- John D. Rogers; Anna Sanchez-Saffon; Alan B. Frol; Ramon Diaz-Arrastia
Arch Neurol 2003; 60: 59-64.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Effect of Levetiracetam on Rapid Motor Learning in Humans
- Young H. Sohn; Han Y. Jung; Alain Kaelin-Lang; Mark Hallett
Arch Neurol 2002; 59: 1909-1912.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Contributions of Dopaminergic Drugs and Disease Severity to Daytime Sleepiness in Parkinson Disease
- Padraig E. O'Suilleabhain; Richard B. Dewey Jr
Arch Neurol 2002; 59: 986-989.
[Abstract]
[Full text]
[PDF]
- Editorials
Viral Infections of the Nervous System, 2002: Update on Diagnosis and Treatment
- John J. Redington; Kenneth L. Tyler
Arch Neurol 2002; 59: 712-718.
[Extract]
[Full text]
[PDF]
- Original Contributions
Antiepileptic Drug–Induced Bone Loss in Young Male Patients Who Have Seizures
- Dennis L. Andress; Judy Ozuna; David Tirschwell; Lucinda Grande; Meshell Johnson; Arnold F. Jacobson; William Spain
Arch Neurol 2002; 59: 781-786.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Budipine Provides Additional Benefit in Patients With Parkinson Disease Receiving a Stable Optimum Dopaminergic Drug Regimen
- Horst Przuntek; Stefan Bittkau; Harald Bliesath; Ulrich Büttner; Gerd Fuchs; Joachim Glass; Harald Haller; Thomas Klockgether; Peter Kraus; Lutz Lachenmayer; Dieter Müller; Thomas Müller; Bernhard Rathay; Jörg Sgonina; Volker Steinijans; Elemer Teshmar; Gudrun Ulm; Dieter Volc
Arch Neurol 2002; 59: 803-806.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Evaluation of Dyskinesias in a Pilot, Randomized, Placebo-Controlled Trial of Remacemide in Advanced Parkinson Disease
- Parkinson Study Group
Arch Neurol 2001; 58: 1660-1668.
[Abstract]
[Full text]
[PDF]
|
|
